Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA-11 PET/MRI for Detection of Regional Nodal and Distant Metastases in Patients With Intermediate and High-Risk Prostate Cancer
NCT02678351Phase 3Completed
- Sponsor
- Andrei Iagaru
- Start
- Apr 2016
- Primary completion
- Dec 2020
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of gallium ga-68 gozetotide in prostate adenocarcinoma, sponsored by Andrei Iagaru. Started Apr 2016; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT02678351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678351.